These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1553350)

  • 1. Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.
    Pasini CE; Indelicato JM
    Pharm Res; 1992 Feb; 9(2):250-4. PubMed ID: 1553350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous acidic degradation of the carbacephalosporin loracarbef.
    Skibic MJ; Taylor KW; Occolowitz JL; Collins MW; Paschal JW; Lorenz LJ; Spangle LA; Dorman DE; Baertschi SW
    J Pharm Sci; 1993 Oct; 82(10):1010-7. PubMed ID: 8254485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPTLC assay of cephalexin and cefaclor in pharmaceuticals.
    Agbaba D; Eric S; Zivanov Stakic D; Vladimirov S
    Biomed Chromatogr; 1998; 12(3):133-5. PubMed ID: 9646911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants.
    Andrasi M; Buglyo P; Zekany L; Gaspar A
    J Pharm Biomed Anal; 2007 Sep; 44(5):1040-7. PubMed ID: 17537608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine.
    Kovach PM; Lantz RJ; Brier G
    J Chromatogr; 1991 Jun; 567(1):129-39. PubMed ID: 1918240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical properties of amphoteric beta-lactam antibiotics. IV. First- and second-order degradations of cefaclor and cefatrizine in aqueous solution and kinetic interpretation of the intestinal absorption and degradation of the concentrated antibiotics.
    Nakashima E; Tsuji A; Nakamura M; Yamana T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2098-106. PubMed ID: 4053234
    [No Abstract]   [Full Text] [Related]  

  • 7. Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake.
    Dantzig AH; Tabas LB; Bergin L
    Biochim Biophys Acta; 1992 Dec; 1112(2):167-73. PubMed ID: 1457450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stability of various cephalosporins in solutions. Cefazolin, cefazedone, cefaclor].
    Kurochkina VB; Larina EL; Libinson GS; Nys PS
    Antibiot Khimioter; 1994 Dec; 39(12):3-7. PubMed ID: 7733784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J; Ruoff GE; Jacobson KD
    Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
    Hyslop DL; Bischoff W
    Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporin and carbacephem nephrotoxicity. Roles of tubular cell uptake and acylating potential.
    Tune BM; Hsu CY; Fravert D
    Biochem Pharmacol; 1996 Feb; 51(4):557-61. PubMed ID: 8619902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of the crystalline form of cefaclor monohydrate and its pharmaceutical preparations.
    Medenecka B; Jelińska A; Zajac M; Bałdyka M; Juszkiewicz K; Oszczapowicz I
    Acta Pol Pharm; 2009; 66(5):563-9. PubMed ID: 19894653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
    Dantzig AH; Duckworth DC; Tabas LB
    Biochim Biophys Acta; 1994 Apr; 1191(1):7-13. PubMed ID: 8155686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy for urinary tract infections.
    Iravani A; Bischoff W
    Am J Med; 1992 Jun; 92(6A):95S-100S. PubMed ID: 1621753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of degradation of cefazolin and cephalexin in aqueous solution.
    Rattie ES; Guttman DE; Ravin LJ
    Arzneimittelforschung; 1978; 28(6):944-8. PubMed ID: 35181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical properties of amphoteric beta-lactam antibiotics. II: Solubility and dissolution behavior of aminocephalosporins as a function of pH.
    Tsuji A; Nakashima E; Yamana T
    J Pharm Sci; 1979 Mar; 68(3):308-11. PubMed ID: 34022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative stability of cephalosporins in aqueous solution: kinetics and mechanisms of degradation.
    Yamana T; Tsuji A
    J Pharm Sci; 1976 Nov; 65(11):1563-74. PubMed ID: 11330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the simultaneous measurement of several cephalosporins by RP-HPLC (I)].
    Wu ZJ; Guo WB; Zhang QG; Ni KY; Lin YS
    Se Pu; 1999 Nov; 17(6):518-21. PubMed ID: 12552680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loracarbef vs. cefaclor in pediatric skin and skin structure infections.
    Hanfling MJ; Hausinger SA; Squires J
    Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S27-30. PubMed ID: 1513609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.